Publications

Chakraborty, S., G. Andrieux, P. Kastl, L. Adlung, S. Altamura, M. E. Boehm, L. E. Schwarzmuller, Y. Abdullah, M. C. Wagner, B. Helm, H. J. Grone, W. D. Lehmann, M. Boerries, H. Busch, M. U. Muckenthaler, M. Schilling, and U. Klingmuller. 2022. Erythropoietin-driven dynamic proteome adaptations during erythropoiesis prevent iron overload in the developing embryo. Cell Rep 40: 111360. doi: 10.1016/j.celrep.2022.111360.

Melendez, A. V., R. M. Velasco Cardenas, S. Lagies, J. Strietz, L. Siukstaite, O. S. Thomas, J. Tomisch, W. Weber, B. Kammerer, W. Romer, and S. Minguet. 2022. Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells. Cell Mol Life Sci 79: 513. doi: 10.1007/s00018-022-04524-7.

Ho, J., D. Schmidt, T. Lowinus, J. Ryoo, E. P. Dopfer, N. Gonzalo Nunez, S. Costa-Pereira, C. Toffalori, M. Punta, V. Fetsch, T. Wertheimer, M. C. Rittmann, L. M. Braun, M. Follo, C. Briere, J. M. Vinnakota, M. Langenbach, F. Koppers, K. Shoumariyeh, H. Engel, T. Ruckert, M. Marklin, S. Holzmayer, A. L. Illert, F. Magon, G. Andrieux, S. Duquesne, D. Pfeifer, J. Staniek, M. Rizzi, C. Miething, N. Kohler, J. Duyster, H. D. Menssen, M. Boerries, J. M. Buescher, N. Cabezas-Wallscheid, B. R. Blazar, P. Apostolova, L. Vago, E. L. Pearce, B. Becher, and R. Zeiser. 2022. Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation. Blood 140: 1167-1181. doi: 10.1182/blood.2022016082.

Braig, D., A. Runkel, A. E. Eisenhardt, A. Schmid, J. Zeller, T. Pauli, U. Lausch, J. Wehrle, P. Bronsert, M. Jung, J. Kiefer, M. Boerries, and S. U. Eisenhardt. 2022. Individualized Mini-Panel Sequencing of ctDNA Allows Tumor Monitoring in Complex Karyotype Sarcomas. Int J Mol Sci 23: pii: ijms231810215. doi: 10.3390/ijms231810215.

Schultz, A., M. Schnurra, A. El-Bizri, N. M. Woessner, S. Hartmann, R. Hartig, S. Minguet, B. Schraven, and L. Simeoni. 2022. A Cysteine Residue within the Kinase Domain of Zap70 Regulates Lck Activity and Proximal TCR Signaling. Cells 11. pii: cells11172723. doi: 10.3390/cells11172723.

Fliegauf, M., M. Kinnunen, S. Posadas-Cantera, N. Camacho-Ordonez, H. Abolhassani, L. Alsina, F. Atschekzei, D. J. Bogaert, S. O. Burns, J. A. Church, G. Duckers, A. F. Freeman, L. Hammarstrom, L. G. Hanitsch, T. Kerre, R. Kobbe, S. O. Sharapova, K. Siepermann, C. Speckmann, S. Steiner, N. Verma, J. E. Walter, E. Westermann-Clark, S. Goldacker, K. Warnatz, M. Varjosalo, and B. Grimbacher. 2022. Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50. Front Immunol 13: 965326. doi: 10.3389/fimmu.2022.965326.

Aktories, P., P. Petry, P. Glatz, G. Andrieux, A. Oschwald, H. Botterer, O. Gorka, D. Erny, M. Boerries, P. Henneke, O. Gross, M. Prinz, and K. Kierdorf. 2022. An improved organotypic cell culture system to study tissue-resident macrophages ex vivo. Cell Rep Methods 2: 100260. doi: 10.1016/j.crmeth.2022.100260.

Ramirez, N., S. Posadas-Cantera, N. Langer, A. C. G. de Oteyza, M. Proietti, B. Keller, F. Zhao, V. Gernedl, M. Pecoraro, H. Eibel, K. Warnatz, E. Ballestar, R. Geiger, C. Bossen, and B. Grimbacher. 2022. Multi-omics analysis of naive B cells of patients harboring the C104R mutation in TACI. Front Immunol 13: 938240. doi: 10.3389/fimmu.2022.938240.

Ehl, S., and R. Thimme. 2022. Immune-mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox. Eur J Immunol 52: 1386-1389. doi: 10.1002/eji.202250069.

Karlowitz, R., M. L. Stanifer, J. Roedig, G. Andrieux, D. Bojkova, M. Bechtel, S. Smith, L. Kowald, R. Schubert, M. Boerries, J. Cinatl, Jr., S. Boulant, and S. J. L. van Wijk. 2022. USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING. Cell Death Dis 13: 684. doi: 10.1038/s41419-022-05124-w.

Lehr, S., F. Meiss, D. Kiritsi, and L. Tsakiris. 2022. Small-Vessel Vasculitis After ST-Segment Elevation Myocardial Infarction: Clopidogrel or Amiodarone? JACC Case Rep 4: 967-971. doi: 10.1016/j.jaccas.2022.05.008.

Lehr, S., F. Felber, I. Tantcheva-Poor, C. Kessler, R. Eming, A. Nystrom, M. Rizzi, and D. Kiritsi. 2022. Occurrence of autoantibodies against skin proteins in patients with hereditary epidermolysis bullosa predisposes to development of autoimmune blistering disease. Front Immunol 13: 945176. doi: 10.3389/fimmu.2022.945176.

Hennig C, Graaf A, Petric PP, Graf L, Schwemmle M, Beer M, Harder T. Porcine Health Manag. 2022. Are pigs overestimated as a source of zoonotic influenza viruses? First published: 2022 Jun 30;8(1):30. doi: 10.1186/s40813-022-00274-x. PMID: 35773676 Free PMC article

Biavasco, F., G. Ihorst, R. Wasch, C. Wehr, H. Bertz, J. Finke, and R. Zeiser. 2022. Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract. Bone Marrow Transplant 57: 1500-1506. doi: 10.1038/s41409-022-01741-3.

Globig AM, Hipp AV, Otto-Mora P, Heeg M, Mayer LS, Ehl S, Schwacha H, Bewtra M, Tomov V, Thimme R, Hasselblatt P, Bengsch B. Nat Commun. 2022. High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature. First published: 2022 Jun 27;13(1):3688. doi: 10.1038/s41467-022-31229-z. PMID: 35760777 Free PMC article.

Tanriver, U., F. Emmerich, J. F. Hummel, B. Janigen, M. Panning, F. Arnold, and Y. Tanriver. 2022. IFNL4 rs368234815 polymorphism does not predict risk of BK virus associated nephropathy after living-donor kidney transplant: A case-control study. Clin Transplant 36: e14663. doi: 10.1111/ctr.14663.